CIVADE
Toulouse, Occitanie, 31000, France
NCT Number: NCT04359056
Clinical pharmacy is a patient-centered discipline and improves significantly the safety of drug management. Regarding medications, clinical pharmacy is efficient. The investigator hypothesize that clinical pharmacy applied to medical devices could be as effective as in the medication field.
The main objective of this study is to assess the effectiveness of clinical pharmacy activities during entire care pathways of patients implanted with a PICC line, in preventing complications.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Toulouse, Occitanie, 31000, France
This is a preliminary, before-after, monocentric and prospective study. The study will begin with an observational period and will be followed by an experimental intervention period. Sixty-nine adult patients in each period will be included. During the observational phase, no clinical pharmacy activities will be performed. During the interventional phase, clinical pharmacists will be active during the entire patients' care pathways.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
PICC line implantation: Optimize the logistics circuit of the PICC line by rationalizing orders through the evaluation of potential losses.
Ensure the due traceability of the implanted medical device. Discharge order : Analysis, optimization and pharmaceutical interventions if necessary Discharge Pharmaceutical Interview : Discussion with the patient, Information about the PICC line maintenance and associated therapies, Information about the prescribed drugs.
Call to the community pharmacist to transfer the patient's prescription. Follow-up calls for 3 months after discharge
Time frame: 3 months
Number of complications per patient and per month in each group. Number of complications per patient and per month in each group
Time frame: 3 months
Rates of consultations and rehospitalizations in each group.
Time frame: 3 months
Number of potentially inappropriate prescriptions resulting in an accepted PI over total of PIs.
Time frame: day 0
Number of correct items over total (items checklist about stock, supply chain, traceability)
Time frame: day 0
Number of correct items over total (items checklist about recommended indications, implantation duration, etc.)
Time frame: day 0
Conformity rates per phase.
Time frame: at discharge
EQ-5D-5L score
Time frame: 3 months
EQ-5D-5L score
Time frame: 3 months
Assessment of patients' satisfactions regarding their therapeutic management
Time frame: 3 months
assessment of healthcare professionals' satisfactions regarding their collaboration with the pharmacists
Time frame: 3 months
description and evaluation of the direct medical costs
University Hospital, Toulouse
Other
Integration of Clinical Pharmacy Along the Entire Care Pathway of Patients Implanted with a PICC-line
Acronym: CLIPICC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05412108
Catheter Complications
Le Mans, France
View Trial DetailsNCT05741866
Cardiovascular Diseases, Catheter Complications
Herston, Queensland, Australia
View Trial DetailsNCT05380661
Anxiety Disorders, Anxiety State
Vancouver, British Columbia, Canada
View Trial DetailsNCT06014099
Catheter Complications
Hangzhou, Zhejiang, China
View Trial Details